CatapultRx Grant Funding
We are pleased to be awarded the grant by CPI as part of the CatapultRx: Medicines Manufacturing Start and Scale programme, which will be delivered in partnership with the Medicines Discovery Catapult. The award will explore the platform-like potential of PDE targets through new methodology development.
Vinnova grant — DOUBLE BARRIER
We are pleased to be awarded a grant by Vinnova as part of an international collaboration with Sahlgrenska University Hospital, Imperial College London, the National Institutes of Health, and Research Institutes of Sweden. The DOUBLE BARRIER project integrates AI-driven multi-omics diagnostics and next-generation prevention strategies to combat bacterial infections and AMR.
LinkedIn announcement → More information →Innovate UK Biomedical Catalyst Accelerator — Future Medicines
We are pleased to announce Veirulence's participation in the Innovate UK Biomedical Catalyst Accelerator — Future Medicines. The programme provides engagement with drug discovery, development, and regulation experts. The Pre-Accelerator runs November–December, with selected companies progressing to the Accelerator in January–March 2026.
LinkedIn announcement → More information →Innovate UK — AMR Sweden Global Business Innovation Programme
We are pleased to announce Veirulence's successful application to join the Innovate UK — AMR Sweden Global Business Innovation Programme (GBIP). Veirulence will visit Sweden in November to build collaborations and partnerships and explore innovation opportunities.
LinkedIn announcement → More information →